CD44 Cancer Research Results
CD44, CD44: Click to Expand ⟱
| Source: |
| Type: |
CD44 represents a common biomarker of cancer stem cells, and promotes epithelial-mesenchymal transition. CD44 is a well-known marker of CSCs and plays important roles in tumor initiation and development.
|
CRC, Colorectal Cancer: Click to Expand ⟱
Colorectal cancer is a broader term that encompasses both colon and rectal cancer.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
CRC, |
HT29 |
|
|
|
CSCs↓, TumCP↓, cycD1/CCND1↓, p27↑, P21↑, TumCCA↑, Apoptosis↑, ChemoSen↑, β-catenin/ZEB1↓, FTO↑, CD44↓, CD133↓, ChemoSen↑,
TumCP↓, TumCCA↑, CD44↓, CSCs↓, NOTCH↓,
| - |
vitro+vivo, |
CRC, |
TCO1 |
|
|
|
- |
vitro+vivo, |
CRC, |
TCO2 |
|
|
|
cycD1/CCND1↓, cMyc↓, p‑ERK↓, CD44↓, CD133↓, LGR5↓, TumCCA↑, TumVol↓, CSCs↓,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
CRC, |
HCT8 |
|
|
|
TumCP↓, TumCMig↓, CD44↓, CSCs↓,
NF-kB↓, FAK↓, Ki-67↓, MMP9↓, CSCs↓, CD44↓, CD133↓, ALDH1A1↓, EMT↓, ChemoSen↑, Hif1a↓, ITGB1↓, Inflam↓,
Showing Research Papers: 1 to 5 of 5
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 5
Pathway results for Effect on Cancer / Diseased Cells:
Core Metabolism/Glycolysis ⓘ
cMyc↓, 1,
Cell Death ⓘ
Apoptosis↑, 1, p27↑, 1,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 2, P21↑, 1, TumCCA↑, 3,
Proliferation, Differentiation & Cell State ⓘ
ALDH1A1↓, 1, CD133↓, 3, CD44↓, 5, CSCs↓, 5, EMT↓, 1, p‑ERK↓, 1, LGR5↓, 1, NOTCH↓, 1,
Migration ⓘ
FAK↓, 1, FTO↑, 1, ITGB1↓, 1, Ki-67↓, 1, MMP9↓, 1, TumCMig↓, 1, TumCP↓, 3, β-catenin/ZEB1↓, 1,
Angiogenesis & Vasculature ⓘ
Hif1a↓, 1,
Immune & Inflammatory Signaling ⓘ
Inflam↓, 1, NF-kB↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 3,
Clinical Biomarkers ⓘ
Ki-67↓, 1,
Functional Outcomes ⓘ
TumVol↓, 1,
Total Targets: 28
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: CD44, CD44
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:6 Cells:% prod#:% Target#:48 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page